Ergoteles’s Clorox CLX Stock Holding History

Ergoteles’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-92,531	Closed	-$13M	–	1331
2022 Q4	$13M	Buy	+92,531	New	+$13.1M	0.48%	45
2022 Q2	–	Sell	-72,978	Closed	-$10.1M	–	1683
2022 Q1	$10.1M	Buy	+72,978	New	+$11.2M	0.38%	57
2021 Q2	–	Sell	-2,586	Closed	-$499K	–	1514
2021 Q1	$499K	Buy	+2,586	New	+$498K	0.02%	481

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's CLX Position: Q1 2023 in Review

Ergoteles sold out of Clorox (CLX) in Q1 2023, closing a stake of 92,531 shares — an estimated $13M sold.

Ergoteles first reported a position in CLX in Q1 2021 and held it in 3 quarters. The position peaked at $13M in Q4 2022. 1,139 funds tracked by Wall St. Rank hold CLX as of Q1 2023.

Ergoteles reported no remaining Clorox position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 92,531 Clorox shares in Q1 2023, an estimated $13M.
Ergoteles first reported a position in Clorox in Q1 2021 and held it in 3 quarters.
Ergoteles's Clorox position peaked at $13M in Q4 2022.
1,139 funds tracked by Wall St. Rank held Clorox as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.